DENTSPLY SIRONA’s (XRAY) Sell (D-) Rating Reiterated at Weiss Ratings

Weiss Ratings restated their sell (d-) rating on shares of DENTSPLY SIRONA (NASDAQ:XRAY) in a report released on Wednesday,Weiss Ratings reports.

A number of other brokerages have also recently weighed in on XRAY. Needham & Company LLC restated a “hold” rating on shares of DENTSPLY SIRONA in a research note on Friday, September 26th. Barrington Research reduced their price objective on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set an “outperform” rating for the company in a research note on Friday, August 8th. Wells Fargo & Company cut their target price on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating for the company in a research note on Friday, August 8th. Wall Street Zen upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Friday, September 26th. Finally, Evercore ISI dropped their price objective on shares of DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating on the stock in a report on Wednesday. Two equities research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $18.00.

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock opened at $11.83 on Wednesday. The firm has a fifty day simple moving average of $13.50 and a 200-day simple moving average of $14.61. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13. DENTSPLY SIRONA has a 1-year low of $11.69 and a 1-year high of $24.93. The stock has a market capitalization of $2.36 billion, a price-to-earnings ratio of -2.50, a PEG ratio of 0.76 and a beta of 0.96.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share for the quarter, topping analysts’ consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The business had revenue of $936.00 million during the quarter, compared to analysts’ expectations of $929.67 million. During the same period in the previous year, the company earned $0.49 earnings per share. DENTSPLY SIRONA’s revenue for the quarter was down 4.9% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. On average, sell-side analysts expect that DENTSPLY SIRONA will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, October 10th. Stockholders of record on Friday, September 26th were issued a $0.16 dividend. The ex-dividend date of this dividend was Friday, September 26th. This represents a $0.64 annualized dividend and a dividend yield of 5.4%. DENTSPLY SIRONA’s dividend payout ratio is presently -13.50%.

Institutional Investors Weigh In On DENTSPLY SIRONA

Several large investors have recently made changes to their positions in the company. Sound Income Strategies LLC grew its holdings in shares of DENTSPLY SIRONA by 26.2% in the 3rd quarter. Sound Income Strategies LLC now owns 461,924 shares of the medical instruments supplier’s stock worth $5,645,000 after purchasing an additional 95,980 shares during the last quarter. 1620 Investment Advisors Inc. grew its holdings in shares of DENTSPLY SIRONA by 7.1% in the 3rd quarter. 1620 Investment Advisors Inc. now owns 23,468 shares of the medical instruments supplier’s stock worth $298,000 after purchasing an additional 1,554 shares during the last quarter. Central Pacific Bank Trust Division grew its holdings in shares of DENTSPLY SIRONA by 100.0% in the 3rd quarter. Central Pacific Bank Trust Division now owns 4,000 shares of the medical instruments supplier’s stock worth $51,000 after purchasing an additional 2,000 shares during the last quarter. Corient Private Wealth LLC bought a new stake in DENTSPLY SIRONA during the 2nd quarter worth about $487,000. Finally, Cim Investment Management Inc. grew its holdings in DENTSPLY SIRONA by 99.7% during the 2nd quarter. Cim Investment Management Inc. now owns 48,321 shares of the medical instruments supplier’s stock worth $842,000 after acquiring an additional 24,120 shares during the last quarter. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.